{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:29:38Z","timestamp":1772166578305,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Incentive programs are an effective yet underutilized behavioral intervention that can improve outcomes in medication for opioid use disorder (MOUD) treatment. Contingency Management (CM) is a rigorous incentive program run per seven evidence-based principles (e.g. objectively verifiable target behaviors, frequent opportunities for incentives). Prior implementation attempts have focused on implementing CM in specialized addiction clinics with methadone as the primary medication treatment. However, many people get MOUD from less specialized, more accessible family medicine clinics. These clinics might also benefit from the use of incentive programs, yet present unique challenges for implementation. For example, family medicine clinics typically use buprenorphine as their primary medication, which requires less intensive dosing schedules than methadone and thus provides fewer incentive opportunities. As an initial step in user-centered design of a CM-informed incentive program for the family medicine context, we conducted qualitative interviews with patients and staff in the buprenorphine treatment program of a family medicine department. We gathered and analyzed qualitative data on CM knowledge, preferred program parameters, and implementation considerations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      Participants (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200924) were buprenorphine treatment staff (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912) and patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912). Participants completed 30\u201350-minute semi-structured interviews, analyzed using rapid matrix analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Participants had little experience with formal incentive programs, but generally viewed incentives as acceptable, appropriate, and feasible. Interviewees coalesced around having staff who were not MOUD prescribers run the program, consistent rather than escalating payments, and physical rewards delivered in-person. Potential challenges included medical record integration, demands on staff time, and confirmation of patients\u2019 goal completion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patient and staff feedback was well-aligned, especially regarding rewards as an opportunity for staff-patient connection and the need for simplicity. Comparing end-user suggestions with the literature, some consensus suggestions (e.g. non-escalating rewards) highlighted feasible places to compromise on ideal effectiveness to gain implementability. However, others (e.g. use of self-report to verify goals) conflicted directly with CM principles and indicate where more intensive education, support, and monitoring will be needed for implementation fidelity. These findings inform user-centered design and iteration of an incentive program for this accessible, non-specialized family medicine setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13722-025-00621-7","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:23:46Z","timestamp":1766413426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implementing incentives in family medicine for opioid use disorder treatment: a qualitative inquiry on provider and patient preferences for a low magnitude reward program compatible with buprenorphine treatment"],"prefix":"10.1186","volume":"20","author":[{"given":"Samantha","family":"Ellis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jax","family":"Witzig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Basaldu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Rudd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Gastala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra R.","family":"Tabachnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sungha","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tondalaya","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Stackhouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Wardle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"621_CR1","unstructured":"Nicholas E Hagemeier, P. Introduction to the opioid epidemic: the economic burden on the healthcare system and impact on quality of life. 2018. https:\/\/www.ajmc.com\/view\/intro-opioid-epidemic-economic-burden-on-healthcare-system-impact-quality-of-life."},{"issue":"2","key":"621_CR2","doi-asserted-by":"publisher","first-page":"e1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","volume":"3","author":"SE Wakeman","year":"2020","unstructured":"Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, Azocar F, Sanghavi DM. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2):e1920622. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.20622.","journal-title":"JAMA Netw Open Open"},{"key":"621_CR3","doi-asserted-by":"crossref","unstructured":"Amura CR. Outcomes from the medication assisted treatment pilot program for adults with opioid use disorders in rural Colorado. 2022.","DOI":"10.21203\/rs.3.rs-769124\/v1"},{"key":"621_CR4","unstructured":"DEA. Drug scheduling. n.d. https:\/\/www.dea.gov\/drug-information\/drug-scheduling. Retrieved July 27, 2025, from."},{"issue":"2","key":"621_CR5","doi-asserted-by":"publisher","first-page":"100177","DOI":"10.1016\/j.focus.2023.100177","volume":"3","author":"BE Meyerson","year":"2024","unstructured":"Meyerson BE, Bentele KG, Brady BR, Stavros N, Russell DM, Mahoney AN, Garnett I, Jackson S, Garcia RC, Coles HB, Granillo B, & Carter GA. Insufficient impact: limited implementation of federal regulatory changes to methadone and buprenorphine access in Arizona during COVID-19. AJPM Focus. 2024;3(2):100177. https:\/\/doi.org\/10.1016\/j.focus.2023.100177.","journal-title":"AJPM Focus"},{"issue":"6","key":"621_CR6","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1377\/hlthaff.2019.01622","volume":"39","author":"M Olfson","year":"2020","unstructured":"Olfson M, Zhang V, Schoenbaum M, King M. Buprenorphine treatment by primary care providers, psychiatrists, addiction specialists, and others. Health Affairs. 2020;39(6):984\u201392. https:\/\/doi.org\/10.1377\/hlthaff.2019.01622.","journal-title":"Health Aff (millwood)"},{"issue":"1","key":"621_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13311-019-00814-4","volume":"17","author":"AJ Abraham","year":"2020","unstructured":"Abraham AJ, Andrews CM, Harris SJ, Friedmann PD. Availability of medications for the treatment of alcohol and opioid use disorder in the USA. Neurotherapeutics. 2020;17(1):55\u201369. https:\/\/doi.org\/10.1007\/s13311-019-00814-4.","journal-title":"Neurotherapeutics"},{"issue":"7","key":"621_CR8","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/j.1360-0443.2009.02627.x","volume":"104","author":"J Bell","year":"2009","unstructured":"Bell J, Trinh L, Butler B, Randall D, Rubin G. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment. Addiction. 2009;104(7):1193\u2013200. https:\/\/doi.org\/10.1111\/j.1360-0443.2009.02627.x.","journal-title":"Addiction"},{"issue":"6","key":"621_CR9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S2215-0366(23)00095-0","volume":"10","author":"L Degenhardt","year":"2023","unstructured":"Degenhardt L, Clark B, Macpherson G, Leppan O, Nielsen S, Zahra E, Larance B, Kimber J, Martino-Burke D, Hickman M, Farrell M. Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies. Lancet Psychiatry. 2023;10(6):386\u2013402. https:\/\/doi.org\/10.1016\/S2215-0366(23)00095-0.","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"621_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","volume":"35","author":"C Timko","year":"2016","unstructured":"Timko C, Schultz NR, Cucciare MA, Vittorio L, Garrison-Diehn C. Retention in medication-assisted treatment for opiate dependence: a systematic review. J Addictive Dis. 2016;35(1):22\u201335. https:\/\/doi.org\/10.1080\/10550887.2016.1100960.","journal-title":"J Addictive Dis"},{"key":"621_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jsat.2018.09.001","volume":"95","author":"H Samples","year":"2018","unstructured":"Samples H, Williams AR, Olfson M, Crystal S. Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees. J Subst Abuse Treat. 2018;95:9\u201317. https:\/\/doi.org\/10.1016\/j.jsat.2018.09.001.","journal-title":"J Subst Abuse Treat"},{"key":"621_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.1969","author":"HA Bol\u00edvar","year":"2021","unstructured":"Bol\u00edvar HA, Klemperer EM, Coleman SRM, DeSarno M, Skelly JM, Higgins ST. Contingency management for patients receiving medication for opioid use disorder. JAMA Psychiarty. 2021. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.1969.","journal-title":"JAMA Psychiarty"},{"key":"621_CR13","unstructured":"ATTC Network Wide. Motivational incentives: positive reinforcers to enhance successful treatment outcomes (MI: PRESTO) - addiction technology transfer center (ATTC) network. 2013. https:\/\/attcnetwork.org\/products_and_resources\/motivational-incentives-positive-reinforcers-to-enhance-successful-treatment-outcomes-mi-presto\/."},{"issue":"3","key":"621_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s40614-019-00204-3","volume":"42","author":"CJ Rash","year":"2019","unstructured":"Rash CJ, DePhilippis D. Considerations for implementing contingency management in substance abuse treatment clinics: the veterans affairs initiative as a model. Perspectives Behav Sci. 2019;42(3):479\u201399. https:\/\/doi.org\/10.1007\/s40614-019-00204-3.","journal-title":"Perspectives On Behav Sci"},{"key":"621_CR15","doi-asserted-by":"publisher","unstructured":"Roll J, Shoptaw S. Contingency management: schedule effects. Psychiatry Res. 2006;144(1). https:\/\/doi.org\/10.1016\/j.psychres.2005.12.003.","DOI":"10.1016\/j.psychres.2005.12.003"},{"key":"621_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2025.1341","author":"CJ Rash","year":"2025","unstructured":"Rash CJ, Black SI, Parent SC, Erath TG, McDonell MG. Data-driven contingency management incentive magnitudes: a review. JAMA Psychiarty. 2025. https:\/\/doi.org\/10.1001\/jamapsychiatry.2025.1341.","journal-title":"JAMA Psychiarty"},{"key":"621_CR17","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/j.ypmed.2012.04.017","volume":"55","author":"A DeFulio","year":"2012","unstructured":"DeFulio A, Silverman K. The use of incentives to reinforce medication adherence. Preventative Med. 2012;55(SUPPL.), S86\u201394. https:\/\/doi.org\/10.1016\/j.ypmed.2012.04.017.","journal-title":"Preventative Med"},{"issue":"2","key":"621_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/ADM.0000000000000193","volume":"10","author":"K Dugosh","year":"2016","unstructured":"Dugosh K, Abraham A, Seymour B, McLoyd K, Chalk M, Festinger D. A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction. J Addict Med. 2016;10(2):93. https:\/\/doi.org\/10.1097\/ADM.0000000000000193.","journal-title":"J Addict Med"},{"issue":"1","key":"621_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0376-8716(99)00068-X","volume":"58","author":"JD Griffith","year":"2000","unstructured":"Griffith JD, Rowan-Szal GA, Roark RR, Simpson DD. Contingency management in outpatient methadone treatment: a meta-analysis. Drug Alcohol Depen. 2000;58(1):55\u201366. https:\/\/doi.org\/10.1016\/S0376-8716(99)00068-X.","journal-title":"Drug Alcohol Depen"},{"issue":"2","key":"621_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1360-0443.2006.01311.x","volume":"101","author":"JP Lussier","year":"2006","unstructured":"Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction. 2006;101(2):192\u2013203. https:\/\/doi.org\/10.1111\/j.1360-0443.2006.01311.x.","journal-title":"Addiction"},{"issue":"11","key":"621_CR21","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/j.1360-0443.2006.01581.x","volume":"101","author":"M Prendergast","year":"2006","unstructured":"Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction. 2006;101(11):1546\u201360. https:\/\/doi.org\/10.1111\/j.1360-0443.2006.01581.x.","journal-title":"Addiction"},{"key":"621_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jsat.2018.09.004","volume":"95","author":"SA Helseth","year":"2018","unstructured":"Helseth SA, Janssen T, Scott K, Squires DD, Becker SJ. Training community-based treatment providers to implement contingency management for opioid addiction: time to and frequency of adoption. J Subst Abuse Treat. 2018;95:26\u201334. https:\/\/doi.org\/10.1016\/j.jsat.2018.09.004.","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"621_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jsat.2004.03.003","volume":"26","author":"MP McGovern","year":"2004","unstructured":"McGovern MP, Fox TS, Xie H, Drake RE. A survey of clinical practices and readiness to adopt evidence-based practices: dissemination research in an addiction treatment system. J Subst Abuse Treat. 2004;26(4):305\u201312. https:\/\/doi.org\/10.1016\/j.jsat.2004.03.003.","journal-title":"J Subst Abuse Treat"},{"key":"621_CR24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.drugalcdep.2017.12.020","volume":"185","author":"D DePhilippis","year":"2018","unstructured":"DePhilippis D, Petry NM, Bonn-Miller MO, Rosenbach SB, McKay JR. The national implementation of Contingency Management (CM) in the department of veterans affairs: attendance at CM sessions and substance use outcomes. Drug Alcohol Depen. 2018;185:367\u201373. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.12.020.","journal-title":"Drug Alcohol Depen"},{"issue":"1","key":"621_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13722-021-00268-0","volume":"16","author":"SJ Becker","year":"2021","unstructured":"Becker SJ, Murphy CM, Hartzler B, Rash CJ, Janssen T, Roosa M, Madden LM, Garner BR. Project mimic (Maximizing Implementation of Motivational Incentives in Clinics): a cluster-randomized type 3 hybrid effectiveness-implementation trial. Addict Sciamp; Clin Pract. 2021;16(1):61. https:\/\/doi.org\/10.1186\/s13722-021-00268-0.","journal-title":"Addict Sciamp; Clin Pract"},{"issue":"1","key":"621_CR26","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s12913-019-4308-6","volume":"19","author":"SJ Becker","year":"2019","unstructured":"Becker SJ, Scott K, Murphy CM, Pielech M, Moul SA, Yap KR, Garner BR. User-centered design of contingency management for implementation in opioid treatment programs: a qualitative study. BMC Health Serv Res. 2019;19(1):466. https:\/\/doi.org\/10.1186\/s12913-019-4308-6.","journal-title":"BMC Health Serv Res"},{"key":"621_CR27","doi-asserted-by":"publisher","first-page":"107614","DOI":"10.1016\/j.ypmed.2023.107614","volume":"176","author":"SC Parent","year":"2023","unstructured":"Parent SC, Peavy KM, Tyutyunnyk D, Hirchak KA, Nauts T, Dura A, Weed L, Barker L, McDonell MG. Lessons learned from statewide contingency management rollouts addressing stimulant use in the Northwestern United States. Preventative Med. 2023;176:107614. https:\/\/doi.org\/10.1016\/j.ypmed.2023.107614.","journal-title":"Preventative Med"},{"key":"621_CR28","doi-asserted-by":"publisher","unstructured":"Pfund RA, Ginley MK, Rash CJ, Zajac K. Contingency management for treatment attendance: a meta-analysis. J Subst Abuse Treat. 2021;108556. https:\/\/doi.org\/10.1016\/j.jsat.2021.108556.","DOI":"10.1016\/j.jsat.2021.108556"},{"key":"621_CR29","doi-asserted-by":"publisher","first-page":"107594","DOI":"10.1016\/j.ypmed.2023.107594","volume":"176","author":"SJ Becker","year":"2023","unstructured":"Becker SJ, DiClemente-Bosco K, Rash CJ, Garner BR. Effective, but underused: lessons learned implementing contingency management in real-world practice settings in the United States. Preventative Med. 2023;176:107594\u2013107594. https:\/\/doi.org\/10.1016\/j.ypmed.2023.107594.","journal-title":"Preventative Med"},{"issue":"1","key":"621_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13012-023-01297-w","volume":"18","author":"SJ Becker","year":"2023","unstructured":"Becker SJ, DiClemente-Bosco K, Scott K, Janssen T, Salino SM, Hasan FN, Yap KR, Garner BR. Implementing contingency management for stimulant use in opioid treatment programs: protocol of a type III hybrid effectiveness-stepped-wedge trial. Implementation Sci : IS. 2023;18(1):41\u201341. https:\/\/doi.org\/10.1186\/s13012-023-01297-w.","journal-title":"Implementation Sci : IS"},{"issue":"4","key":"621_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jsat.2013.12.007","volume":"46","author":"B Hartzler","year":"2014","unstructured":"Hartzler B, Jackson TR, Jones BE, Beadnell B, Calsyn DA. Disseminating contingency management: impacts of staff training and implementation at an opiate treatment program. J Subst Abuse Treat. 2014;46(4):429\u201338. https:\/\/doi.org\/10.1016\/j.jsat.2013.12.007.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"621_CR32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1037\/a0026826","volume":"80","author":"NM Petry","year":"2012","unstructured":"Petry NM, Alessi SM, Ledgerwood DM. A randomized trial of contingency management delivered by community therapists. J Consult Clin Psych. 2012;80(2):286\u201398. https:\/\/doi.org\/10.1037\/a0026826.","journal-title":"J Consult Clin Psych"},{"issue":"1","key":"621_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.drugalcdep.2011.09.015","volume":"122","author":"NM Petry","year":"2012","unstructured":"Petry NM, Alessi SM, Ledgerwood DM. Contingency management delivered by community therapists in outpatient settings. Drug Alcohol Depen. 2012;122(1):86\u201392. https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.09.015.","journal-title":"Drug Alcohol Depen"},{"key":"621_CR34","doi-asserted-by":"publisher","first-page":"107726","DOI":"10.1016\/j.ypmed.2023.107726","volume":"176","author":"HW Clark","year":"2023","unstructured":"Clark HW, Davis M. Federal legal and regulatory aspects of contingency management incentives. Preventative Med. 2023;176:107726. https:\/\/doi.org\/10.1016\/j.ypmed.2023.107726.","journal-title":"Preventative Med"},{"issue":"33","key":"621_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/adaw.32812","volume":"32","author":"A Knopf","year":"2020","unstructured":"Knopf A. HHS OIG doubles down on constraints against contingency management. Alcohol & Drug Abuse Wkly. 2020;32(33):1\u20135. https:\/\/doi.org\/10.1002\/adaw.32812.","journal-title":"Alcohol & Drug Abuse Wkly"},{"key":"621_CR36","volume-title":"Using SAMHSA funds to implement evidence-based contingency management services","author":"SAMHSA","year":"2025","unstructured":"SAMHSA. Using SAMHSA funds to implement evidence-based contingency management services. 2025."},{"key":"621_CR37","doi-asserted-by":"publisher","first-page":"209079","DOI":"10.1016\/j.josat.2023.209079","volume":"151","author":"CJ Rash","year":"2023","unstructured":"Rash CJ. Implementing an evidence-based prize contingency management protocol for stimulant use. J Retailing Subst Addict Treat. 2023;151:209079. https:\/\/doi.org\/10.1016\/j.josat.2023.209079.","journal-title":"J Retailing Subst Use And Addict Treat"},{"issue":"9938","key":"621_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0140-6736(14)60196-3","volume":"384","author":"T Weaver","year":"2014","unstructured":"Weaver T, Metrebian N, Hellier J, Pilling S, Charles V, Little N, Poovendran D, Mitcheson L, Ryan F, Bowden-Jones O, Dunn J, Glasper A, Finch E, Strang J. Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial. Lancet. 2014;384(9938):153\u201363. https:\/\/doi.org\/10.1016\/S0140-6736(14)60196-3.","journal-title":"Lancet"},{"issue":"7","key":"621_CR39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1176\/appi.ajp.20240261","volume":"182","author":"CJ Rash","year":"2025","unstructured":"Rash CJ, McDonell M, Erath T, Parent S, Rawson R, Wattenberg S. A call to action: evidence-based contingency management. Am J Psychiatry. 2025;182(7):599\u2013602. https:\/\/doi.org\/10.1176\/appi.ajp.20240261.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"621_CR40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/cpsp.12154","volume":"23","author":"AR Lyon","year":"2016","unstructured":"Lyon AR, Koerner K. User-centered design for psychosocial intervention development and implementation. Clin Phychol: Sci Pract. 2016;23(2):180\u2013200. https:\/\/doi.org\/10.1111\/cpsp.12154.","journal-title":"Clin Phychol: Sci Pract"},{"issue":"6","key":"621_CR41","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1177\/104973230201200611","volume":"12","author":"JB Averill","year":"2002","unstructured":"Averill JB. Matrix analysis as a complementary analytic strategy in qualitative inquiry. Qualitative Health Res. 2002;12(6):855\u201366. https:\/\/doi.org\/10.1177\/104973230201200611.","journal-title":"Qualitative Health Res"},{"issue":"2","key":"621_CR42","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.drugalcdep.2005.01.016","volume":"79","author":"MW Lewis","year":"2005","unstructured":"Lewis MW, Petry NM. Contingency management treatments that reinforce completion of goal-related activities: participation in family activities and its association with outcomes. Drug Alcohol Depen. 2005;79(2):267\u201371. https:\/\/doi.org\/10.1016\/j.drugalcdep.2005.01.016.","journal-title":"Drug Alcohol Depen"},{"issue":"10","key":"621_CR43","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1037\/ccp0000330","volume":"86","author":"NM Petry","year":"2018","unstructured":"Petry NM, Alessi SM, Rash CJ, Barry D, Carroll KM. A randomized trial of contingency management reinforcing attendance at treatment: do duration and timing of reinforcement matter. J Consult Clin Psych. 2018;86(10):799\u2013809. https:\/\/doi.org\/10.1037\/ccp0000330.","journal-title":"J Consult Clin Psych"},{"issue":"9","key":"621_CR44","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1016\/j.addbeh.2013.03.018","volume":"38","author":"JM Roll","year":"2013","unstructured":"Roll JM, Chudzynski J, Cameron JM, Howell DN, McPherson S. Duration effects in contingency management treatment of methamphetamine disorders. Addictive Behaviors. 2013;38(9):2455\u201362. https:\/\/doi.org\/10.1016\/j.addbeh.2013.03.018.","journal-title":"Addictive Behaviors"},{"issue":"1","key":"621_CR45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1037\/ccp0000552","volume":"89","author":"MK Ginley","year":"2021","unstructured":"Ginley MK, Pfund RA, Rash CJ, Zajac K. Long-term efficacy of contingency management treatment based on objective indicators of abstinence from illicit substance use up to 1 year following treatment: a meta-analysis. J Consult Clin Psych. 2021;89(1):58\u201371. https:\/\/doi.org\/10.1037\/ccp0000552.","journal-title":"J Consult Clin Psych"},{"key":"621_CR46","doi-asserted-by":"publisher","first-page":"209522","DOI":"10.1016\/j.josat.2024.209522","volume":"167","author":"CJ Rash","year":"2024","unstructured":"Rash CJ, Alessi SM, Zajac K. Examining the impact of low magnitude incentives in contingency management protocols: non-engagement in petry et al. 2004. J Retailing Subst Addict Treat. 2024;167:209522. https:\/\/doi.org\/10.1016\/j.josat.2024.209522.","journal-title":"J Retailing Subst Use And Addict Treat"},{"key":"621_CR47","doi-asserted-by":"publisher","first-page":"208941","DOI":"10.1016\/j.josat.2022.208941","volume":"151","author":"B Hartzler","year":"2023","unstructured":"Hartzler B, Gray K, Marx M, Kirk-Lewis K, Payne-Smith K, McIlveen JW. Community implementation of contingency management to address stimulant use. J Retailing Subst Addict Treat. 2023;151:208941. https:\/\/doi.org\/10.1016\/j.josat.2022.208941.","journal-title":"J Retailing Subst Use And Addict Treat"},{"key":"621_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jsat.2016.06.012","volume":"72","author":"F Kropp","year":"2017","unstructured":"Kropp F, Lewis D, Winhusen T. The effectiveness of ultra-low magnitude reinforcers: findings from a \u201creal-world\u201d application of contingency management. J Subst Abuse Treat. 2017;72:111\u201316. https:\/\/doi.org\/10.1016\/j.jsat.2016.06.012.","journal-title":"J Subst Abuse Treat"},{"key":"621_CR49","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN. The REDCap consortium: building an international community of software platform partners. J Educ Chang Biomed Inf. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Educ Chang Biomed Inf"},{"issue":"2","key":"621_CR50","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J Educ Chang Biomed Inf. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Educ Chang Biomed Inf"},{"key":"621_CR51","unstructured":"Hamilton A. Qualitative methods in rapid turn-around health services research. 2013. https:\/\/www.hsrd.research.va.gov\/for_researchers\/cyber_seminars\/archives\/video_archive.cfm?SessionID=780."},{"key":"621_CR52","doi-asserted-by":"crossref","unstructured":"Nevedal AL, Reardon CM, Opra Widerquist MA, Jackson GL, Cutrona SL, White BS, Damschroder LJ. Rapid versus traditional qualitative analysis using the Consolidated Framework for Implementation Research (CFIR). Implementation Sci. 2021;16(1):67.","DOI":"10.1186\/s13012-021-01111-5"},{"key":"621_CR53","unstructured":"Gale RC, Wu J, Erhardt T, Bounthavong M, Reardon CM, Damschroder L, Midboe A. Comparison of rapid vs In-depth qualitative analytic methods from a process evaluation of academic detailing in the veterans health administration\u2014University of Illinois at Chicago library. (2019).https:\/\/i-share-uic.primo.exlibrisgroup.com\/discovery\/fulldisplay?docid=cdi_doaj_primary_oai_doaj_org_article_c0f2c1513d1c4ccc83799eeda89237b9%26context=PC%26vid=01CARLI_UIC:CARLI_UIC%26lang=en%26search_scope=MyInst_and_CI%26adaptor=Primo%20Central%26tab=LibraryCatalogPlus%26query=any,contains,Gale,%20R.C.,%20Wu,%20J.,%20Erhardt,%20T.,%20Bounthavong,%20M.,%20Reardon,%20C.,%20Damschroder,%20L.,%20%26%20Midboe,%20A.%20(2019).%20%20Comparison%20of%20rapid%20vs.%20in-depth%20qualitative%20analytic%20methods%20from%20a%20process%20evaluation%20of%20academic%20detailing%20in%20the%20Veterans%20Health%20Administration.%20Implementation%20Science,%2014(11),%20pages%20unavailable.%20https:%2F%2Fdoi.org%2F10.1186%2Fs13012-019-0853-y%26offset=0."},{"issue":"10","key":"621_CR54","doi-asserted-by":"publisher","first-page":"e019993","DOI":"10.1136\/bmjopen-2017-019993","volume":"8","author":"B Taylor","year":"2018","unstructured":"Taylor B, Henshall C, Kenyon S, Litchfield I, Greenfield S. Can rapid approaches to qualitative analysis deliver timely, valid findings to clinical leaders? A mixed methods study comparing rapid and thematic analysis. BMJ Open. 2018;8(10):e019993\u2013019993. https:\/\/doi.org\/10.1136\/bmjopen-2017-019993.","journal-title":"BMJ Open"},{"issue":"2","key":"621_CR55","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/19359705.2021.1995096","volume":"26","author":"A Harkness","year":"2022","unstructured":"Harkness A, Weinstein ER, Atuluru P, Hernandez Altamirano D, Vidal R, Rodriguez-Diaz CE, Safren SA. Latino sexual minority men\u2019s intersectional minority stress, general stress, and coping during COVID-19: a rapid qualitative study. J Gay Lesbian Ment Health. 2022;26(2):130\u201357. https:\/\/doi.org\/10.1080\/19359705.2021.1995096.","journal-title":"J Gay Lesbian Ment Health"},{"issue":"1","key":"621_CR56","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1016\/j.sapharm.2021.05.013","volume":"18","author":"CP Renfro","year":"2022","unstructured":"Renfro CP, Rome Z, Gatwood J, Hohmeier KC. Use of rapid assessment procedures when analyzing qualitative data in pharmacy research. Res Soc Adm Pharm. 2022;18(1):2249\u201353. https:\/\/doi.org\/10.1016\/j.sapharm.2021.05.013.","journal-title":"Res Soc Adm Pharm"},{"issue":"11","key":"621_CR57","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1176\/appi.ps.202000250","volume":"71","author":"L Uscher-Pines","year":"2020","unstructured":"Uscher-Pines L, Sousa J, Raja P, Mehrotra A, Barnett ML, Huskamp HA. Suddenly becoming a \u201cVirtual Doctor\u201d: experiences of psychiatrists transitioning to telemedicine during the COVID-19 Pandemic. Psychiatric Serv (wash, D.C.). 2020;71(11):1143\u201350. https:\/\/doi.org\/10.1176\/appi.ps.202000250.","journal-title":"Psychiatric Serv (wash, D.C.)"},{"key":"621_CR58","doi-asserted-by":"publisher","DOI":"10.1037\/tps0000245","author":"K Scott","year":"2020","unstructured":"Scott K, Murphy CM, Yap K, Moul S, Hurley L, Becker SJ. Health professional stigma as a barrier to contingency management implementation in opioid treatment programs. Transl Issues Psychol Sci. 2020. https:\/\/doi.org\/10.1037\/tps0000245.","journal-title":"Transl Issues Psychol Sci"},{"issue":"1","key":"621_CR59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1037\/adb0000496","volume":"34","author":"CJ Rash","year":"2019","unstructured":"Rash CJ, Alessi SM, Zajac K. Examining implementation of contingency management in real-world settings. Phychol Addictive Behaviors. 2019;34(1):89. https:\/\/doi.org\/10.1037\/adb0000496.","journal-title":"Phychol Addictive Behaviors"},{"issue":"1","key":"621_CR60","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0376-8716(99)00071-X","volume":"58","author":"NM Petry","year":"2000","unstructured":"Petry NM. A comprehensive guide to the application of contingency management procedures in clinical settings. Drug Alcohol Depen. 2000;58(1):9\u201325.","journal-title":"Drug Alcohol Depen"},{"issue":"3","key":"621_CR61","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.drugalcdep.2005.11.023","volume":"83","author":"NM Petry","year":"2006","unstructured":"Petry NM, Kolodner KB, Li R, Peirce JM, Roll JM, Stitzer ML, Hamilton JA. Prize-based contingency management does not increase gambling. Drug Alcohol Depen. 2006;83(3):269\u201373. https:\/\/doi.org\/10.1016\/j.drugalcdep.2005.11.023.","journal-title":"Drug Alcohol Depen"},{"issue":"3","key":"621_CR62","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1037\/a0023617","volume":"19","author":"Y Washio","year":"2011","unstructured":"Washio Y, Higgins ST, Heil SH, McKerchar TL, Badger GJ, Skelly JM, Dantona RL. Delay discounting is associated with treatment response among cocaine-dependent outpatients. Exp Clin Psychopharmacol. 2011;19(3):243\u201348. https:\/\/doi.org\/10.1037\/a0023617.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"621_CR63","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF03395538","volume":"56","author":"JM Roll","year":"2006","unstructured":"Roll JM, Huber A, Sodano R, Chudzynski JE, Moynier E, Shoptaw S. A comparison of five reinforcement schedules for use in contingency management-based treatment of methamphetamine abuse. Psychol Rec. 2006;56(1):67\u201381. https:\/\/doi.org\/10.1007\/BF03395538.","journal-title":"Psychol Rec"},{"issue":"1","key":"621_CR64","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.drugalcdep.2006.03.010","volume":"85","author":"KC Kirby","year":"2006","unstructured":"Kirby KC, Benishek LA, Dugosh KL, Kerwin ME. Substance abuse treatment providers\u2019 beliefs and objections regarding contingency management: implications for dissemination. Drug Alcohol Depen. 2006;85(1):19\u201327. https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.03.010.","journal-title":"Drug Alcohol Depen"},{"key":"621_CR65","volume-title":"An unexplored equity factor: differential beliefs and attitudes toward contingency management by providers\u2019 ethnicit","author":"O Oluwoye","year":"2023","unstructured":"Oluwoye O, Weeks DL, McDonell MG. An unexplored equity factor: differential beliefs and attitudes toward contingency management by providers\u2019 ethnicit. 2023."},{"issue":"3","key":"621_CR66","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.drugalcdep.2011.08.027","volume":"121","author":"CJ Rash","year":"2012","unstructured":"Rash CJ, Petry NM, Kirby KC, Martino S, Roll J, Stitzer ML. Identifying provider beliefs related to contingency management adoption using the contingency management beliefs questionnaire. Drug Alcohol Depen. 2012;121(3):205\u201312. https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.08.027.","journal-title":"Drug Alcohol Depen"},{"key":"621_CR67","volume-title":"Federal guidelines for opioid treatment programs","author":"SAMHSA","year":"2024","unstructured":"SAMHSA. Federal guidelines for opioid treatment programs. 2024."}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-025-00621-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-025-00621-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-025-00621-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:23:48Z","timestamp":1766413428000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13722-025-00621-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["621"],"URL":"https:\/\/doi.org\/10.1186\/s13722-025-00621-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6347618\/v1","asserted-by":"object"}]},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were approved by the Institutional Review Board at the University of Illinois Chicago. All participants gave informed consent prior to participating.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declaration"}},{"value":"Margaret Wardle reports financial support was provided by University of Illinois at Chicago Center for Clinical and Translational Science (CCTS). Brittany Rudd reports a relationship with The National Center for State Courts that includes: consulting or advisory. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}